[Analysis of the current status and related factors of antiviral treatment for chronic hepatitis B virus infection in rural communities of Zhangqiu District, Jinan City].

X M Zhang, B Y Yan, J J Lyu, Y Feng, X Meng, C Z Cao, L Zhang
{"title":"[Analysis of the current status and related factors of antiviral treatment for chronic hepatitis B virus infection in rural communities of Zhangqiu District, Jinan City].","authors":"X M Zhang, B Y Yan, J J Lyu, Y Feng, X Meng, C Z Cao, L Zhang","doi":"10.3760/cma.j.cn112150-20240813-00651","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To investigate the current status and related factors of antiviral treatment for chronic hepatitis B virus (HBV) infection in rural communities in China. <b>Methods:</b> In 2023, 866 chronic HBV-infected individuals from rural communities in Zhangqiu District, Jinan City, were included in the study. Basic information, disease status and antiviral treatment conditions of the infected individuals were collected through questionnaires, specimen collection and laboratory tests. Univariate and multivariate logistic regression were used to analyze the related factors of the antiviral treatment rate of those who met the indications for hepatitis B antiviral treatment. <b>Results:</b> The median age (<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>) of subjects was 56 (48, 66) years old, among which 436 (50.4%) were males. There were 712 (82.2%) individuals who met the indications for hepatitis B antiviral treatment, and 110 individuals received antiviral treatment with a rate of 15.5%. Multivariate logistic regression analysis showed that compared with males, families with an average monthly income per capita of <1 000 yuan, no alcohol consumption, no smoking, and a family history of HBV infection, females (<i>OR</i>=4.66, 95%<i>CI</i>: 2.88-7.53), families with an average monthly income per capita of 1 000-1 999 yuan (<i>OR</i>=1.64, 95%<i>CI</i>: 1.00-2.68) and ≥2 000 yuan (<i>OR</i>=2.78, 95%<i>CI</i>: 1.54-5.03), alcohol consumption (<i>OR</i>=6.42, 95%<i>CI</i>: 2.80-14.7), smoking (<i>OR</i>=1.98, 95%<i>CI</i>: 1.04-3.77), and no family history of HBV infection (<i>OR</i>=1.90, 95%<i>CI</i>: 1.16-3.09) had a lower antiviral treatment rate for chronic HBV infection. <b>Conclusion:</b> The antiviral treatment rate of chronic HBV-infected individuals in rural communities of Zhangqiu District, Jinan City is low, and the related factors are female, high monthly income per capita, alcohol consumption, smoking, and no family history of HBV infection.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 3","pages":"286-291"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华预防医学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112150-20240813-00651","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate the current status and related factors of antiviral treatment for chronic hepatitis B virus (HBV) infection in rural communities in China. Methods: In 2023, 866 chronic HBV-infected individuals from rural communities in Zhangqiu District, Jinan City, were included in the study. Basic information, disease status and antiviral treatment conditions of the infected individuals were collected through questionnaires, specimen collection and laboratory tests. Univariate and multivariate logistic regression were used to analyze the related factors of the antiviral treatment rate of those who met the indications for hepatitis B antiviral treatment. Results: The median age (Q1, Q3) of subjects was 56 (48, 66) years old, among which 436 (50.4%) were males. There were 712 (82.2%) individuals who met the indications for hepatitis B antiviral treatment, and 110 individuals received antiviral treatment with a rate of 15.5%. Multivariate logistic regression analysis showed that compared with males, families with an average monthly income per capita of <1 000 yuan, no alcohol consumption, no smoking, and a family history of HBV infection, females (OR=4.66, 95%CI: 2.88-7.53), families with an average monthly income per capita of 1 000-1 999 yuan (OR=1.64, 95%CI: 1.00-2.68) and ≥2 000 yuan (OR=2.78, 95%CI: 1.54-5.03), alcohol consumption (OR=6.42, 95%CI: 2.80-14.7), smoking (OR=1.98, 95%CI: 1.04-3.77), and no family history of HBV infection (OR=1.90, 95%CI: 1.16-3.09) had a lower antiviral treatment rate for chronic HBV infection. Conclusion: The antiviral treatment rate of chronic HBV-infected individuals in rural communities of Zhangqiu District, Jinan City is low, and the related factors are female, high monthly income per capita, alcohol consumption, smoking, and no family history of HBV infection.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
济南市章丘区农村社区慢性乙型肝炎病毒感染抗病毒治疗现状及相关因素分析
目的:了解中国农村社区慢性乙型肝炎病毒(HBV)感染的抗病毒治疗现状及相关因素。方法:选取2023年济南市章丘区农村社区慢性hbv感染者866例为研究对象。通过问卷调查、标本采集、实验室检测等方式收集感染者的基本信息、疾病状况及抗病毒治疗情况。采用单因素和多因素logistic回归分析符合乙肝抗病毒治疗指征者抗病毒治疗率的相关因素。结果:受试者的中位年龄(Q1、Q3)为56岁(48、66)岁,其中男性436人(50.4%)。符合乙肝抗病毒治疗指征的有712人(82.2%),接受抗病毒治疗的有110人,占15.5%。多因素logistic回归分析显示,与男性相比,家庭人均月收入为OR=4.66, 95%CI: 2.88 ~ 7.53)、家庭人均月收入为1 000 ~ 1 999元(OR=1.64, 95%CI: 1.00 ~ 2.68)、家庭人均月收入≥2 000元(OR=2.78, 95%CI: 1.54 ~ 5.03)、饮酒(OR=6.42, 95%CI: 2.80 ~ 14.7)、吸烟(OR=1.98, 95%CI: 1.04 ~ 3.77)、无HBV感染家族史(OR=1.90, 95%CI: 1.90)、家庭人均月收入为1 000 ~ 1 999元(OR=1.64, 95%CI: 1.00 ~ 2.68)、家庭人均月收入为1 000 ~ 1 999元)、家庭人均月收入为1 000 ~ 1 999元(OR= 1.78, 95%CI: 1.54 ~ 5.03)。1.16-3.09)对慢性HBV感染的抗病毒治疗率较低。结论:济南市章丘区农村社区慢性HBV感染者抗病毒药物治疗率较低,相关因素为女性、人均月收入高、饮酒、吸烟、无HBV感染家族史。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
中华预防医学杂志
中华预防医学杂志 Medicine-Medicine (all)
CiteScore
1.20
自引率
0.00%
发文量
12678
期刊介绍: Chinese Journal of Preventive Medicine (CJPM), the successor to Chinese Health Journal , was initiated on October 1, 1953. In 1960, it was amalgamated with the Chinese Medical Journal and the Journal of Medical History and Health Care , and thereafter, was renamed as People’s Care . On November 25, 1978, the publication was denominated as Chinese Journal of Preventive Medicine . The contents of CJPM deal with a wide range of disciplines and technologies including epidemiology, environmental health, nutrition and food hygiene, occupational health, hygiene for children and adolescents, radiological health, toxicology, biostatistics, social medicine, pathogenic and epidemiological research in malignant tumor, surveillance and immunization.
期刊最新文献
[Molecular characteristics and antimicrobial susceptibility of 31 clinical invasive isolates of Streptococcus dysgalactiae subspecies equisimilis in 5 provinces of China]. [Current status and challenges of standard formulation in the field of infectious disease prevention and control in China]. [Research and development progress of pneumococcal conjugate vaccines based on the serotype distribution characteristics of pneumococci in China]. [Expert consensus on the multidisciplinary integrated management of atopic dermatitis and its comorbidities(2026 edition)]. [Development and application of amplification-free nucleic acid detection in molecular diagnostics].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1